301 related articles for article (PubMed ID: 22768329)
21. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
Anagnostis P; Katsiki N; Adamidou F; Athyros VG; Karagiannis A; Kita M; Mikhailidis DP
Metabolism; 2013 Jan; 62(1):21-33. PubMed ID: 22652056
[TBL] [Abstract][Full Text] [Related]
22. Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
Li G; Hernandez-Ono A; Crooke RM; Graham MJ; Ginsberg HN
Metabolism; 2012 Jun; 61(6):823-35. PubMed ID: 22209663
[TBL] [Abstract][Full Text] [Related]
23. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
[TBL] [Abstract][Full Text] [Related]
24. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
Prasad Sakamuri SS; Sukapaka M; Prathipati VK; Nemani H; Putcha UK; Pothana S; Koppala SR; Ponday LR; Acharya V; Veetill GN; Ayyalasomayajula V
PLoS One; 2012; 7(12):e50216. PubMed ID: 23284633
[TBL] [Abstract][Full Text] [Related]
25. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101.
Hong SP; Han D; Chang KH; Ahn SK
Eur J Pharmacol; 2018 Sep; 835():169-178. PubMed ID: 30096297
[TBL] [Abstract][Full Text] [Related]
26. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice.
Alberts P; Engblom L; Edling N; Forsgren M; Klingström G; Larsson C; Rönquist-Nii Y; Ohman B; Abrahmsén L
Diabetologia; 2002 Nov; 45(11):1528-32. PubMed ID: 12436336
[TBL] [Abstract][Full Text] [Related]
28. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
[TBL] [Abstract][Full Text] [Related]
29. Salicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization.
Nixon M; Wake DJ; Livingstone DE; Stimson RH; Esteves CL; Seckl JR; Chapman KE; Andrew R; Walker BR
Diabetes; 2012 Apr; 61(4):790-6. PubMed ID: 22357964
[TBL] [Abstract][Full Text] [Related]
30. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
[TBL] [Abstract][Full Text] [Related]
31. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
32. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
[TBL] [Abstract][Full Text] [Related]
33. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice.
Wamil M; Battle JH; Turban S; Kipari T; Seguret D; de Sousa Peixoto R; Nelson YB; Nowakowska D; Ferenbach D; Ramage L; Chapman KE; Hughes J; Dunbar DR; Seckl JR; Morton NM
Diabetes; 2011 Apr; 60(4):1158-67. PubMed ID: 21350084
[TBL] [Abstract][Full Text] [Related]
34. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
[TBL] [Abstract][Full Text] [Related]
35. Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice.
Véniant MM; Hale C; Komorowski R; Chen MM; St Jean DJ; Fotsch C; Wang M
Diabetes Obes Metab; 2009 Feb; 11(2):109-17. PubMed ID: 18479468
[TBL] [Abstract][Full Text] [Related]
36. 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis.
Kipari T; Hadoke PW; Iqbal J; Man TY; Miller E; Coutinho AE; Zhang Z; Sullivan KM; Mitic T; Livingstone DE; Schrecker C; Samuel K; White CI; Bouhlel MA; Chinetti-Gbaguidi G; Staels B; Andrew R; Walker BR; Savill JS; Chapman KE; Seckl JR
FASEB J; 2013 Apr; 27(4):1519-31. PubMed ID: 23303209
[TBL] [Abstract][Full Text] [Related]
37. Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice.
Wang YJ; Huang SL; Feng Y; Ning MM; Leng Y
Acta Pharmacol Sin; 2012 Sep; 33(9):1195-203. PubMed ID: 22922341
[TBL] [Abstract][Full Text] [Related]
38. Acute anti-obesity effects of intracerebroventricular 11β-HSD1 inhibitor administration in diet-induced obese mice.
Seo M; Islam SA; Moon SS
J Neuroendocrinol; 2018 Mar; 30(3):e12580. PubMed ID: 29418022
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of 11beta-hydroxysteroid dehydrogenase type 1 in LPS-activated J774.1 macrophages--role of 11beta-HSD1 in pro-inflammatory properties in macrophages.
Ishii T; Masuzaki H; Tanaka T; Arai N; Yasue S; Kobayashi N; Tomita T; Noguchi M; Fujikura J; Ebihara K; Hosoda K; Nakao K
FEBS Lett; 2007 Feb; 581(3):349-54. PubMed ID: 17239856
[TBL] [Abstract][Full Text] [Related]
40. Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.
Lee JH; Gao Z; Ye J
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1035-41. PubMed ID: 23512810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
